Publication | Closed Access

Brain natriuretic peptide as a marker for hypertensive left ventricular hypertrophy: Changes during 1-year antihypertensive therapy with angiotensin-converting enzyme inhibitor

HypertensionHeart FailureBlood PressureCardiovascular DiseaseBrain Natriuretic PeptideMedicinePhysiologyAntihypertensive TherapyCardiovascular PharmacologyVentricular HypertrophyEndocrine HypertensionPublic HealthPharmacology1-Year Antihypertensive TherapyAtherosclerosisDiastolic FunctionCardiovascular Imaging